Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Scottsdale Healthcare
With
National Foundation for Cancer Research
Translational Genomics Research Institute
1. To measure the time from biopsy to completion and final analysis of Whole Genome Sequencing (WGS) on patient tumor and non-tumor samples.
2. To examine the frequency with which useable sequence data is obtained as a function of tumor volume received and percent tumor involvement in the biopsy
3. To identify the frequency with which potential targets and pathways for therapy are discovered.
4. To observe for any evidence that if anti-tumor activity from treatment is noted how would the genome sequencing have correlated with that activity.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a life expectancy of greater than 3 months.
Patients must have a diagnosis of histologically or cytologically confirmed advanced incurable cancer which has progressed on one or more prior chemotherapeutic, hormonal or biological regimens for advanced disease.
Be a good medical candidate for and willing to undergo a biopsy or surgical procedure to obtain tissue, which may or may not be part of the patient's routine care for their malignancy.
You may not be if
Patients with symptomatic CNS metastasis.
Known HIV, HBV or HCV infection requiring antiviral therapy.
Pregnant or breast-feeding patients or any patient with childbearing potential not using adequate contraception.
